HANGZHOU TIGERMED CONSULTING SAYS UNDER TRANSACTION AGREEMENT, INITIAL PRICE FOR TARGET BUSINESS AT $470 MLN, NON-TARGET BUSINESS OUTSIDE OF CHINA AT $84.4 MLN, NON-TARGET BUSINESS WITHIN CHINA $205.5 MLN

Reuters · 6d ago

Please log in to view news